182 related articles for article (PubMed ID: 20857911)
1. Synthesis and biological activities of transition metal complexes based on acetylsalicylic acid as neo-anticancer agents.
Rubner G; Bensdorf K; Wellner A; Kircher B; Bergemann S; Ott I; Gust R
J Med Chem; 2010 Oct; 53(19):6889-98. PubMed ID: 20857911
[TBL] [Abstract][Full Text] [Related]
2. [Cyclopentadienyl]metalcarbonyl complexes of acetylsalicylic acid as neo-anticancer agents.
Rubner G; Bensdorf K; Wellner A; Bergemann S; Ott I; Gust R
Eur J Med Chem; 2010 Nov; 45(11):5157-63. PubMed ID: 20828891
[TBL] [Abstract][Full Text] [Related]
3. Antitumor-active cobalt-alkyne complexes derived from acetylsalicylic acid: studies on the mode of drug action.
Ott I; Schmidt K; Kircher B; Schumacher P; Wiglenda T; Gust R
J Med Chem; 2005 Jan; 48(2):622-9. PubMed ID: 15658875
[TBL] [Abstract][Full Text] [Related]
4. Chlorinated cobalt alkyne complexes derived from acetylsalicylic acid as new specific antitumor agents.
Obermoser V; Baecker D; Schuster C; Braun V; Kircher B; Gust R
Dalton Trans; 2018 Mar; 47(12):4341-4351. PubMed ID: 29492489
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterisation and biological evaluation of copper and silver complexes based on acetylsalicylic acid.
Rubner G; Bensdorf K; Wellner A; Bergemann S; Gust R
Arch Pharm (Weinheim); 2011 Oct; 344(10):684-8. PubMed ID: 21984018
[TBL] [Abstract][Full Text] [Related]
6. Fluorination as tool to improve bioanalytical sensitivity and COX-2-selective antitumor activity of cobalt alkyne complexes.
Baecker D; Obermoser V; Kirchner EA; Hupfauf A; Kircher B; Gust R
Dalton Trans; 2019 Nov; 48(42):15856-15868. PubMed ID: 31617517
[TBL] [Abstract][Full Text] [Related]
7. NHC gold halide complexes derived from 4,5-diarylimidazoles: synthesis, structural analysis, and pharmacological investigations as potential antitumor agents.
Liu W; Bensdorf K; Proetto M; Abram U; Hagenbach A; Gust R
J Med Chem; 2011 Dec; 54(24):8605-15. PubMed ID: 22091836
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, cytotoxicity, cellular uptake and influence on eicosanoid metabolism of cobalt-alkyne modified fructoses in comparison to auranofin and the cytotoxic COX inhibitor Co-ASS.
Ott I; Koch T; Shorafa H; Bai Z; Poeckel D; Steinhilber D; Gust R
Org Biomol Chem; 2005 Jun; 3(12):2282-6. PubMed ID: 16010362
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and pharmacological evaluation of 1H-imidazoles as ligands for the estrogen receptor and cytotoxic inhibitors of the cyclooxygenase.
Wiglenda T; Ott I; Kircher B; Schumacher P; Schuster D; Langer T; Gust R
J Med Chem; 2005 Oct; 48(20):6516-21. PubMed ID: 16190777
[TBL] [Abstract][Full Text] [Related]
10. Development of bimetallic titanocene-ruthenium-arene complexes as anticancer agents: relationships between structural and biological properties.
Pelletier F; Comte V; Massard A; Wenzel M; Toulot S; Richard P; Picquet M; Le Gendre P; Zava O; Edafe F; Casini A; Dyson PJ
J Med Chem; 2010 Oct; 53(19):6923-33. PubMed ID: 20822096
[TBL] [Abstract][Full Text] [Related]
11. Anti-oxidant, in vitro, in vivo anti-inflammatory activity and antiproliferative activity of mefenamic acid and its metal complexes with manganese(II), cobalt(II), nickel(II), copper(II) and zinc(II).
Kovala-Demertzi D; Hadjipavlou-Litina D; Staninska M; Primikiri A; Kotoglou C; Demertzis MA
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):742-52. PubMed ID: 18720191
[TBL] [Abstract][Full Text] [Related]
12. Ruthenium-porphyrin conjugates with cytotoxic and phototoxic antitumor activity.
Gianferrara T; Bergamo A; Bratsos I; Milani B; Spagnul C; Sava G; Alessio E
J Med Chem; 2010 Jun; 53(12):4678-90. PubMed ID: 20491441
[TBL] [Abstract][Full Text] [Related]
13. Development of methylated cobalt-alkyne complexes with selective cytotoxicity against COX-positive cancer cell lines.
Baecker D; Sagasser J; Karaman S; Hörmann AA; Gust R
Arch Pharm (Weinheim); 2022 Feb; 355(2):e2100408. PubMed ID: 34893997
[TBL] [Abstract][Full Text] [Related]
14. Investigations on the effects of cobalt-alkyne complexes on leukemia and lymphoma cells: cytotoxicity and cellular uptake.
Ott I; Kircher B; Gust R
J Inorg Biochem; 2004 Mar; 98(3):485-9. PubMed ID: 14987849
[TBL] [Abstract][Full Text] [Related]
15. In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I.
Ottanà R; Carotti S; Maccari R; Landini I; Chiricosta G; Caciagli B; Vigorita MG; Mini E
Bioorg Med Chem Lett; 2005 Sep; 15(17):3930-3. PubMed ID: 15993594
[TBL] [Abstract][Full Text] [Related]
16. Cobalt-alkyne complexes with imidazoline ligands as estrogenic carriers: synthesis and pharmacological investigations.
Schlenk M; Ott I; Gust R
J Med Chem; 2008 Nov; 51(22):7318-22. PubMed ID: 18942824
[TBL] [Abstract][Full Text] [Related]
17. Positional isomerism markedly affects the growth inhibition of colon cancer cells by NOSH-aspirin: COX inhibition and modeling.
Vannini F; Chattopadhyay M; Kodela R; Rao PPN; Kashfi K
Redox Biol; 2015 Dec; 6():318-325. PubMed ID: 26319435
[TBL] [Abstract][Full Text] [Related]
18. Anticancer (hexacarbonyldicobalt)propargyl aryl ethers: synthesis, antiproliferative activity, apoptosis induction, and effect on cellular oxidative stress.
Schimler SD; Hall DJ; Debbert SL
J Inorg Biochem; 2013 Feb; 119():28-37. PubMed ID: 23178649
[TBL] [Abstract][Full Text] [Related]
19. Arene ruthenium complexes as anticancer agents.
Süss-Fink G
Dalton Trans; 2010 Feb; 39(7):1673-88. PubMed ID: 20449402
[TBL] [Abstract][Full Text] [Related]
20. Enantiomerically pure [1, 2-diamino-1-(4-fluorophenyl)butane]platinum(II) complexes: synthesis and antitumor activity against MCF-7 and MDA-MB 231 breast cancer and LnCaP/FGC prostate cancer cell lines.
Dullin A; Dufrasne F; Gelbcke M; Gust R
Arch Pharm (Weinheim); 2004 Dec; 337(12):654-67. PubMed ID: 15597399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
